Skip to main content
3161 Results
 
msf-placeholder
HIV/AIDS

Selecting patients for antiretroviral therapy

This sub-article accompanies the feature Demystifying antiretroviral therapy in resource-poor settings. Project Update - 15 Aug 2003
 
msf-placeholder
HIV/AIDS

Demystifying antiretroviral therapy in resource-poor settings

Today, the debate centres on if antiretroviral therapy is possible in severely resource-constrained environments, and, increasingly, on the best ways to deliver these drugs. In a poor township 30 kilometers outside Cape Town, South Africa, MSF set out to grapple with both of these issues.
Project Update - 15 Aug 2003
 
msf-placeholder
HIV/AIDS

AIDS treatment scale-up efforts threatened

AIDS treatment scale-up efforts threatened. Press Release - 16 Jul 2003
 
msf-placeholder
Côte d'Ivoire

The collapse of healthcare, malnutrition, violence and displacement in western Côte d’Ivoire

In the mobile clinics, MSF is seeing many severely malnourished children who emerge from the bush as Internally Displaced Persons (IDPs). On the other side of the problem, the response to malnutrition has been seriously insufficient. MSF is concerned that its observations made during clinic activities are only a muted reflection of the reality beyond what is learned from consultations. To date there have been no other in-depth assessments of malnutrition patterns in the West. Report - 10 Jul 2003
 
msf-placeholder
Turkmenistan

Dashoguzd: Little optimism in Turkmenistan's TB wards

Masks are hurriedly being handed out at the doorway of the tuberculosis sanatorium. Down the long dark corridor you can see the silhouettes of patients shuffling back to their rooms; ladies with mops and buckets of foul-smelling disinfectant appear out of nowhere and we are ushered in. Into the world of the category two failure and the chronic tuberculosis patient, the category four: the suspect "drug-resistants". Crammed into a room, the rusty iron beds touch one another. Project Update - 9 Jul 2003
 
msf-placeholder
Uzbekistan

To treat or not to treat? Implementation of DOTS in Central Asia

Walk through one of the overcrowded tuberculosis hospitals in Karakalpakstan, Uzbekistan, and the reality of the devastation wreaked by this global pandemic is all too apparent. Project Update - 9 Jul 2003
 
msf-placeholder
Website

Drugs for Neglected Diseases initiative (DNDi)

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases. dndi.org
 
msf-placeholder
DNDi

Neglected diseases kill poor

Diseases that kill millions of poor people every year are ignored by Western firms because drugs to combat them make no money, a new research body said as it was launched on Thursday. Project Update - 4 Jul 2003
 
msf-placeholder
Humanitarian challenges

Charity targets 'forgotten' diseases

Working in conjunction with global research bodies and public health authorities, the charity will spend $250 million over the next 12 years to try to come up with seven new drugs. Project Update - 3 Jul 2003
 
msf-placeholder
DNDi

New Body Set to Fight Killer Diseases West Ignores

Diseases that kill millions of poor people every year are ignored by Western firms because drugs to combat them make no money, a new research body said as it was launched on Thursday. Project Update - 3 Jul 2003
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more